195 related articles for article (PubMed ID: 15491434)
1. Better medication adherence results in greater improvement in severity of psoriasis.
Carroll CL; Feldman SR; Camacho FT; Balkrishnan R
Br J Dermatol; 2004 Oct; 151(4):895-7. PubMed ID: 15491434
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
[TBL] [Abstract][Full Text] [Related]
3. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
4. Adherence to topical therapy increases around the time of office visits.
Feldman SR; Camacho FT; Krejci-Manwaring J; Carroll CL; Balkrishnan R
J Am Acad Dermatol; 2007 Jul; 57(1):81-3. PubMed ID: 17498841
[TBL] [Abstract][Full Text] [Related]
5. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
Carroll CL; Feldman SR; Camacho FT; Manuel JC; Balkrishnan R
J Am Acad Dermatol; 2004 Aug; 51(2):212-6. PubMed ID: 15280839
[TBL] [Abstract][Full Text] [Related]
6. Concomitant treatment of psoriasis of the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a prospective open study in 41 patients.
de Leeuw J; Tank B; Bjerring PJ; Koetsveld S; Neumann M
J Am Acad Dermatol; 2006 Feb; 54(2):266-71. PubMed ID: 16443057
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
[TBL] [Abstract][Full Text] [Related]
8. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis.
Kircik L
J Drugs Dermatol; 2011 Mar; 10(3):270-3. PubMed ID: 21369643
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
12. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
Tiplica GS; Salavastru CM
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
[TBL] [Abstract][Full Text] [Related]
13. Objective assessment of compliance with psoriasis treatment.
Zaghloul SS; Goodfield MJ
Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients.
Brune A; Miller DW; Lin P; Cotrim-Russi D; Paller AS
Pediatr Dermatol; 2007; 24(1):76-80. PubMed ID: 17300658
[TBL] [Abstract][Full Text] [Related]
15. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
[TBL] [Abstract][Full Text] [Related]
17. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques.
Martín Ezquerra G; Sánchez Regaña M; Herrera Acosta E; Umbert Millet P
J Drugs Dermatol; 2006 Apr; 5(4):334-6. PubMed ID: 16673800
[TBL] [Abstract][Full Text] [Related]
18. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
Ortonne JP; van de Kerkhof PC; Prinz JC; Bieber T; Lahfa M; Rubins A; Wozel G; Lorette G;
Acta Derm Venereol; 2006; 86(1):29-33. PubMed ID: 16585986
[TBL] [Abstract][Full Text] [Related]
19. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.
Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
Drugs Exp Clin Res; 2005; 31(4):141-5. PubMed ID: 16223203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]